{
  "slug": "medcrypt",
  "name": "Medcrypt",
  "description": "Medcrypt provides the MSI platform, a comprehensive solution for medical device cybersecurity compliance. It offers tools, data, and expert support to help manufacturers meet FDA requirements, achieve 100% FDA approval on submissions, and maintain continuous compliance by ensuring devices are secure by design.",
  "url": "https://optimly.ai/brand/medcrypt",
  "websiteUrl": "https://medcrypt.com/",
  "logoUrl": "https://logo.clearbit.com/medcrypt.com",
  "baiScore": 54.2,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Medical Device Cybersecurity Solutions",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-24T16:14:21.795Z",
  "verifiedVitals": {
    "website": "https://medcrypt.com",
    "category": "Medical Device Cybersecurity Compliance",
    "what_it_does": "Medcrypt provides the MSI platform, offering tools, data, and expert support to medical device manufacturers for cybersecurity compliance, helping them meet FDA requirements and achieve a 100% FDA approval rate.",
    "primary_audience": "Medical device manufacturers (MDMs)",
    "core_product": "MSI platform",
    "pricing_model": {
      "kind": "freemium",
      "detail": "Medcrypt offers a free readiness check, while also providing expert support and a comprehensive platform for compliance, suggesting a freemium model with additional paid services."
    },
    "parent_ownership": null
  },
  "intentTags": {
    "problemIntents": [
      "Difficulty getting cybersecurity submissions approved by the FDA on the first attempt",
      "Challenges in meeting FDA requirements for medical device cybersecurity compliance",
      "Delays in shipping medical devices due to compliance issues",
      "Risk of falling out of compliance post-approval",
      "Receiving AINN (Additional Information Needed) or hold letters from the FDA",
      "Lack of clear understanding of cybersecurity gaps before submission",
      "Need for a portfolio-level cybersecurity readiness overview for leadership",
      "Navigating evolving regulations like QMSR, EU CRA, and AI in regulatory submissions",
      "Ensuring medical devices are 'secure by design' from conception"
    ],
    "solutionIntents": [
      "Streamlined medical device cybersecurity compliance process",
      "Platform for readiness assessment and gap analysis (MSI)",
      "Tools for generating FDA-compliant documentation",
      "Automated self-audits and vulnerability monitoring",
      "Alerts for changes in regulatory guidance",
      "Access to expert support from former FDA reviewers",
      "Specialized threat modeling services",
      "Rapid response and guidance for AINN/hold letters",
      "Comprehensive portfolio-level readiness reports"
    ],
    "evaluationIntents": [
      "FDA approval rate and guarantees for cybersecurity submissions",
      "Ease of use and efficiency of the MSI platform (e.g., quick readiness checks)",
      "Integration capabilities with existing device architecture for threat modeling",
      "Credibility and expertise of support staff (e.g., former FDA reviewers)",
      "Comprehensiveness of platform features (pre-submission to post-market compliance)",
      "Cost-effectiveness of avoiding delays and ensuring compliance",
      "Adherence to specific regulatory frameworks (FDA, EU CRA)",
      "Support for building security into the device design from the outset"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1790422124553
}